SYSTEMIC MANIFESTATIONS OF CONSTANT CARDIOGENEIC SYNDROME IN CATS: CLINICAL AND ANATOMICAL ANALYSIS
Keywords:
domestic cat, hypertrophic cardiomyopathy, cor pulmonale, nutmeg liver, splenomegaly, pseudomelanosis, pulmonary edema.Abstract
The article presents a comprehensive clinical and anatomical analysis and pathomorphological documentation of a case of chronic biventricular heart failure in a domestic cat, which developed as a result of primary cardiomyopathy. By the method of pathological autopsy and macromorphometry, a chain of changes from concentric hypertrophy of the left ventricular myocardium to total venous stasis in the small and large circles of blood circulation was recorded. Analyzing the anamnesis, clinical picture and results of the subsequent pathological autopsy, the most likely diagnosis is hypertrophic cardiomyopathy. After all, most cats with HCM can have an asymptomatic course for a long time. Prolonged disruption of the blood supply to the myocardium of the thickened left ventricle leads to gradual damage and death of cardiomyocytes. A visit to the veterinary clinic and the performed manipulations became a trigger for starting a stress reaction, a sharp increase in the metabolic needs of the body, and heart failure did not allow the animal to cope with the increased load. Acute stress led to severe tachycardia, and further deterioration of diastolic function and acute left ventricular heart failure. The wall of the hypertrophied ventricle loses its physiological property of complete relaxation in the diastole stage, which leads to an increase in diastolic pressure in the left ventricle and left atrium. The above processes led to an increase in pressure in the pulmonary veins and capillaries and their expansion with the development of pulmonary edema and the formation of pleural effusion. Secondary pulmonary hypertension with double ectasia of the pulmonary trunk (8–10 mm), congestive muscat hepatomegaly, pronounced splenomegaly (15.5 cm) and congestive gastroenteropathy with pseudomelanosis were verified. It was established that the direct cause of death was acute alveolar pulmonary edema and terminal asphyxia.
References
(Ed.). (2018). International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study. Journal of Veterinary Internal Medicine, 32(6), 2310. https://doi.org/10.1111/jvim.15285
Bédard, C., Lanevschi‐Pietersma, A., & Dunn, M. (2007). Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy. Veterinary Clinical Pathology, 36(2), 167–172. Portico. https://doi.org/10.1111/j.1939-165x.2007.tb00203.x
Borgeat, K., Connolly, D. J., & Luis Fuentes, V. (2015). Cardiac biomarkers in cats. Journal of Veterinary Cardiology, 17, S74–S86. https://doi.org/10.1016/j.jvc.2015.08.001
Côté, E., & Kittleson, M. D. (2021). The feline cardiomyopathies: 2. Hypertrophic cardiomyopathy. Journal of Feline Medicine and Surgery, 23(11), 1029-1051. doi.org
Fuentes, V. L., Wilkie, L. J., & Connolly, D. J. (2024). Feline hypertrophic cardiomyopathy: Phenotypic expressions, staging, and diagnostic challenges. Veterinary Clinics of North America: Small Animal Practice, 54(3), 511-529. doi.org
Glaewketgarn, N. Assessment of longitudinal systolic funcion by using tissue motion annular displacement in hypertrophic cardiomyopathy cats. https://doi.org/10.58837/chula.the.2023.1074
Grosso, G., & Schober, K. E. (2026). Effect of echocardiographic imaging view and methods on left ventricular wall-thickness measurements in normal cats and cats with hypertrophic cardiomyopathy. Journal of Veterinary Internal Medicine, 40(2). https://doi.org/10.1093/jvimsj/aalag062
Häggström, J., Hogan, D. F., & Green, H. W. (2023). Biventricular congestive heart failure in feline patients: Pathophysiology of systemic venous congestion and body cavity effusions. Journal of Veterinary Cardiology, 47, 34-48. doi.org
Häggström, J., Luis Fuentes, V., & Wess, G. (2015). Screening for hypertrophic cardiomyopathy in cats. Journal of Veterinary Cardiology, 17, S134–S149. https://doi.org/10.1016/j.jvc.2015.07.003
Heitner, S. B. (2018). Novel Medical Therapeutics for Hypertrophic Cardiomyopathy. Hypertrophic Cardiomyopathy, 383–387. https://doi.org/10.1007/978-3-319-92423-6_27
K.M. Meurs, M.M. Norgard, M. Kuan, J. Haggstrom, M. Kittleson, Analysis of 8 Sarcomeric Candidate Genes for Feline Hypertrophic Cardiomyopathy Mutations in Cats with Hypertrophic Cardiomyopathy, Journal of Veterinary Internal Medicine, Volume 23, Issue 4, July-August 2009, Pages 840–843, https://doi.org/10.1111/j.1939-1676.2009.0341.x
Kittleson, M. D., & Côté, E. (2021). The feline cardiomyopathies: 1. General concepts. Journal of Feline Medicine and Surgery, 23(11), 1009-1027. doi.org
Kittleson, M. D., Meurs, K. M., & Harris, S. P. (2015). The genetic basis of hypertrophic cardiomyopathy in cats and humans. Journal of Veterinary Cardiology, 17, S53–S73. https://doi.org/10.1016/j.jvc.2015.03.001
Luis Fuentes, V., Abbott, J., & Rishniw, M. (2022). Update on the diagnosis and management of feline hypertrophic cardiomyopathy. In Practice, 44(8), 475-487. doi.org
Maron, B. J., & Fox, P. R. (2015). Hypertrophic cardiomyopathy in man and cats. Journal of Veterinary Cardiology, 17, S6–S9. https://doi.org/10.1016/j.jvc.2015.03.007
Menciotti, G., Borgarelli, M., & Rishniw, M. (2025). Pulmonary hypertension secondary to left-sided heart disease in cats: Echocardiographic and post-mortem vascular remodeling correlations. Journal of Veterinary Internal Medicine, 39(1), 112-124. doi.org
Neumann, S., & Siegert, S. (2024). Investigation of α-Klotho Concentrations in Serum of Cats Affected by Hypertrophic Cardiomyopathy. Veterinary Sciences, 11(5), 184. https://doi.org/10.3390/vetsci11050184
Rishniw, M. (2024). How much protection does clopidogrel provide to cats with hypertrophic cardiomyopathy? Journal of the American Veterinary Medical Association, 262(10), 1422–1424. https://doi.org/10.2460/javma.24.04.0269
Seo, J. W., & Chang, D. (2023). Gastrointestinal and visceral complications of chronic portal hypertension in cats with congestive heart failure: A pathological perspective. Acta Veterinaria Scandinavica, 65(1), 14. doi.org
Şerbănescu, D., & Codreanu, I. (2023). Comparative study on hypertrophic cardiomyopathy in dogs and cats. Practica Veterinara.ro, 3(1), 18–20. https://doi.org/10.26416/pv.41.3.2023.8679
Wareham, K., & Dean, R. (2016). Atenolol and survival in cats with asymptomatic hypertrophic cardiomyopathy. Veterinary Record, 179(7), 176. Portico. https://doi.org/10.1136/vr.i3837
Wilkie, L. J., Rishniw, M., & Payne, J. R. (2024). Pulmonary artery ectasia and hypertension in cats: A retrospective pathologic study of 45 cases. Veterinary Radiology & Ultrasound, 65(2), 143-152. doi.org
Zini, E., Ferasin, L., & Ferasin, H. (2026). Visceral pathology patterns in cats with terminal congestive heart failure: Systemic venous congestion and nutmeg liver development. Journal of Veterinary Diagnostic Investigation, 38(2), 204-215. doi.org
M. Skrypka, Y. Boyko, I. Zapeka, K. Golovan. Practice of forensic veterinary examination of psycho-emotional stress in the genesis of animal insufficiency and death. Agrarian Bulletin of the Black Sea Region. 2023. No. 106. P. 14–22. https://abbsl.osau.edu.ua/index.php/visnuk/article/view/348/312
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.